Benitec Biopharma Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Cowen Aaron | — | Purchase | 11,587 | $13.44 | $155,729 | 1,848,156 | Dec 23, 2025 |
| Averill Madison Master Fund, Ltd. | — | Purchase | 2,892 | $12.08 | $34,935 | 1,826,653 | Dec 18, 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | — | Purchase | 730,370 | $13.50 | $9,859,995 | 9,538,175 | Nov 7, 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | — | Purchase | 1,267 | $12.63 | $16,002 | 1,068,031 | Mar 31, 2025 |
| Cowen Aaron | — | Purchase | 106,200 | $13.00 | $1,380,600 | 1,066,764 | Mar 26, 2025 |
| BUCHI J KEVIN | — | Gift | 103,626 | — | — | 103,626 | Mar 12, 2025 |
| BUCHI J KEVIN | — | Option Exercise | 51,813 | $3.86 | $199,998 | 103,910 | Feb 27, 2025 |
| Cowen Aaron | — | Purchase | 3,142 | $10.98 | $34,499 | 958,266 | Dec 24, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | — | Purchase | 37,190 | $9.60 | $357,024 | 7,957,365 | Dec 3, 2024 |
| Averill Master Fund, Ltd. | — | Purchase | 12,430 | $9.73 | $120,944 | 7,895,815 | Nov 20, 2024 |
| Averill Master Fund, Ltd. | — | X | 4,605,000 | $3.86 | $17,775,300 | 6,663,415 | Sep 26, 2024 |
| Boston Megan | Executive Director | Purchase | 25,907 | — | — | 25,907 | Aug 11, 2023 |
| BUCHI J KEVIN | — | Purchase | 51,813 | — | — | 52,097 | Aug 11, 2023 |
| Oliveira Steven Michael | — | Purchase | 120,000 | $4.18 | $501,600 | 911,000 | Apr 28, 2021 |